Thermal ablation in renal cell carcinoma: What affects renal function?

References

• Hafez KS, Fergany AF, Novick AC. Nephron sparing surgery for localized renal cell carcinoma: Impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol 1999; 162: 1930–1933
   PubMed Web of Science ®Google Scholar
• Kim EY, Park BK, Kim CK, Lee HM. Clinico-radio-pathologic features of a solitary solid renal mass at MDCT examination. Acta Radiol 2011; 51: 1143–1148
   Google Scholar
• Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: Part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. Am J Roentgenol 2005; 185: 64–71
   PubMed Web of Science ®Google Scholar
• Zagoria RJ, Traver MA, Werle DM, Perini M, Hayasaka S, Clark PE. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. Am J Roentgenol 2007; 189: 429–436
   PubMed Web of Science ®Google Scholar
• Silverman SG, Tuncali K, vanSonnenberg E, Morrison PR, Shankar S, Ramaiya N, et al. Renal tumors: MR imaging-guided percutaneous cryotherapy – Initial experience in 23 patients. Radiology 2005; 236: 716–724
   PubMed Web of Science ®Google Scholar
• Atwell TD, Farrell MA, Leibovich BC, Callstrom MR, Chow GK, Blute ML, et al. Percutaneous renal cryoablation: Experience treating 115 tumors. J Urol 2008; 179: 2136–2140, discussion: 2140–2131
   PubMedGoogle Scholar
• Zagoria RJ, Pettus JA, Rogers M, Werle DM, Childs D, Leyendecker JR. Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma. Urology 2011; 77: 1393–1397
   PubMed Web of Science ®Google Scholar
• Sung HH, Park BK, Kim CK, Choi HY, Lee HM. Comparison of percutaneous radiofrequency ablation and open partial nephrectomy for the treatment of size- and location-matched renal masses. Int J Hyperthermia 2012; 28: 227–234
   PubMed Web of Science ®Google Scholar
• Bourne AE, Kramer BA, Steiner HL, Schwartz BF. Renal insufficiency is not a contraindication for cryoablation of small renal masses. J Endourol 2009; 23: 1195–1198
   PubMedGoogle Scholar
• Pettus JA, Werle DM, Saunders W, Hemal A, Kader AK, Childs D, et al. Percutaneous radiofrequency ablation does not affect glomerular filtration rate. J Endourol 2010; 24: 1687–1691
   PubMed Web of Science ®Google Scholar
• Mues AC, Landman J. Results of kidney tumor cryoablation: Renal function preservation and oncologic efficacy. World J Urol 2010; 28: 565–570
   PubMedGoogle Scholar
• Altunrende F, Autorino R, Hillyer S, Yang B, Laydner H, White MA, et al. Image guided percutaneous probe ablation for renal tumors in 65 solitary kidneys: Functional and oncological outcomes. J Urol 2011; 186: 35–41
   PubMed Web of Science ®Google Scholar
• Wehrenberg-Klee E, Clark TW, Malkowicz SB, Soulen MC, Wein AJ, Mondschein JI, et al. Impact on renal function of percutaneous thermal ablation of renal masses in patients with preexisting chronic kidney disease. J Vasc Interv Radiol 2012; 23: 41–45
   PubMedGoogle Scholar
• Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Renal cell carcinoma: Clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 2003; 226: 417–424
   PubMed Web of Science ®Google Scholar
• Park BK, Kim CK, Lim HK. Renal infarction resulting from segmental arterial injury during radiofrequency ablation of renal tumor in patient with a single kidney. Urology 2009; 73: 442 e9–11
   Google Scholar
• Park BK, Kim CK. Complications of image-guided radiofrequency ablation of renal cell carcinoma: Causes, imaging features and prevention methods. Eur Radiol 2009; 19: 2180–2190
   PubMed Web of Science ®Google Scholar
• Park BK, Kim CK, Moo HL. Arteriovenous fistula after radiofrequency ablation of a renal tumor located within the renal sinus. J Vasc Interv Radiol 2007; 18: 1183–1185
   PubMed Web of Science ®Google Scholar
• Park BK, Kim CK. Percutaneous radio frequency ablation of renal tumors in patients with von Hippel-Lindau disease: Preliminary results. J Urol 2010; 183: 1703–1707
   PubMed Web of Science ®Google Scholar
• Park SY, Park BK, Kim CK, Lee HM, Jeon SS, Seo SI, et al. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease previously undergoing a radical nephrectomy or repeated nephron-sparing surgery. Acta Radiol 2011; 52: 680–685
   PubMed Web of Science ®Google Scholar
• Iwamoto Y, Kanda H, Yamakado K, Soga N, Arima K, Takeda K, et al. Management of renal tumors in Von Hippel-Lindau disease by percutaneous CT fluoroscopic guided radiofrequency ablation: Preliminary results. Fam Cancer 2011; 10: 529–534
   PubMedGoogle Scholar
• Aron M, Gill IS. Minimally invasive nephron-sparing surgery (MINSS) for renal tumours. Part II: Probe ablative therapy. Eur Urol 2007; 51: 348–357
   PubMedGoogle Scholar
• Park BK, Morrison PR, Tatli S, Govindarajulu U, Tuncali K, Judy P, et al. Estimated effective dose of CT-guided percutaneous cryoablation of liver tumors. Eur J Radiol 2012; 81: 1702–1706
   PubMed Web of Science ®Google Scholar
• Goel RK, Kaouk JH. Probe ablative treatment for small renal masses: Cryoablation vs radio frequency ablation. Curr Opin Urol 2008; 18: 467–473
   PubMedGoogle Scholar
• Simmons MN, Fergany AF, Campbell SC. Effect of parenchymal volume preservation on kidney function after partial nephrectomy. J Urol 2011; 186: 405–410
   PubMed Web of Science ®Google Scholar
• Porpiglia F, Fiori C, Bertolo R, Morra I, Russo R, Piccoli G, et al. Long-term functional evaluation of the treated kidney in a prospective series of patients who underwent laparoscopic partial nephrectomy for small renal tumors. Eur Urol 2012; 62: 130–135
   PubMed Web of Science ®Google Scholar
• Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, et al. Renal function after partial nephrectomy: Effect of warm ischemia relative to quantity and quality of preserved kidney. Urology 2012; 79: 356–360
   PubMed Web of Science ®Google Scholar
• Lucas SM, Stern JM, Adibi M, Zeltser IS, Cadeddu JA, Raj GV. Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol 2008; 179: 75–79, discussion: 79–80
   PubMed Web of Science ®Google Scholar
• Raman JD, Raj GV, Lucas SM, Williams SK, Lauer EM, Ahrar K, et al. Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques. BJU Int 2010; 105: 496–500
   PubMed Web of Science ®Google Scholar
• Turna B, Kaouk JH, Frota R, Stein RJ, Kamoi K, Gill IS, et al. Minimally invasive nephron sparing management for renal tumors in solitary kidneys. J Urol 2009; 182: 2150–2157
   PubMed Web of Science ®Google Scholar
• Song C, Bang JK, Park HK, Ahn H. Factors influencing renal function reduction after partial nephrectomy. J Urol 2009; 181: 48–53, discussion: 53–44
   PubMed Web of Science ®Google Scholar
• Weisbrod AJ, Atwell TD, Frank I, Callstrom MR, Farrell MA, Mandrekar JN, et al. Percutaneous cryoablation of masses in a solitary kidney. Am J Roentgenol 2010; 194: 1620–1625
   PubMed Web of Science ®Google Scholar
• Klatte T, Grubmuller B, Waldert M, Weibl P, Remzi M. Laparoscopic cryoablation versus partial nephrectomy for the treatment of small renal masses: Systematic review and cumulative analysis of observational studies. Eur Urol 2011; 60: 435–443
   PubMedGoogle Scholar
• Reed AB, Parekh DJ. Surgical management of von Hippel-Lindau disease: Urologic considerations. Surg Oncol Clin N Am 2009; 18: 157–174,x
   PubMedGoogle Scholar